Mediar Therapeutics
4 known investors
Mediartx develops novel therapies for patients with fibrotic diseases.
BiotechMedical Devices
Founders & leadership
RB
Rahul Ballal, PhDCEO
PY
Paul Yaworsky, PhDCSO
Investors · 4
In the news
- Mediar Therapeutics Announces Oversubscribed $76 Million Series B Financing and Clinical Advancement of First-in-Class Fibrosis Portfolioprnewswire.com · 2026
- Trysignalbasetrysignalbase.com · 2025
- News - Mediar Therapeuticsmediartx.com · 2023
- Mediar raises $105 million to target fibrotic mediators - Mediar Therapeuticsmediartx.com · 2023
- Mediar Therapeutics Raises $105M in Fundingfinsmes.com · 2023
- Mediar Therapeutics - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021